Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11771687 Substituted diazaspiroalkanes as androgen receptor modulators

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Michael E. Jung

Samedy Ouk

Chris Tran

Charles L. Sawyers

John Wongvipat

Date of Patent

October 3, 2023

Patent Application Number

17093047

Date Filed

November 9, 2020

Patent Citations

US Patent 8183274 Treatment of hyperproliferative disorders with diarylhydantoin compounds

US Patent 8445507 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

US Patent 8802689 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

US Patent 9126941 Treatment of hyperproliferative disorders with diarylhydantoin compounds

US Patent 9987261 Substituted diazaspiroalkanes as androgen receptor modulators

US Patent 9388159 Substituted diazaspiroalkanes as androgen receptor modulators

US Patent 10857139 Substituted diazaspiroalkanes as androgen receptor modulators

US Patent 7271188 Imidazolidine derivatives

...

Patent Primary Examiner

Douglas M Willis

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11771687 Substituted diazaspiroalkanes as androgen receptor modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.